PRTH-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRTH-101, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies [Phase 1]